FDA
FDA Articles
Chimerix has announced that its lead drug candidate has been provided for potential use in patients with Ebola virus disease.
Published:
ThinkstockCatalyst Pharmaceutical Partners Inc. (NASDAQ: CPRX) announced positive topline results from its Phase 3 clinical trial of Firdapse for the symptomatic treatment of Lambert-Eaton Myasthenic...
Published:
Alimera Sciences traded up big on Monday on news that the company received FDA approval for its diabetic macular edema drug Iluvien.
Published:
In the after-hours on Wednesday, Flexion Therapeutics made a hard fall on the news of a clinical hold.
Published:
NPS Pharmaceuticals traded lower on what sounded like good news. The problem is that headlines often do not reveal the true underlying story.
Published:
ThinkstockNPS Pharmaceuticals, Inc. (NASDAQ: NPSP) is up huge in regular trading on Wednesday, due to positive preliminary results of a clinical trial. The FDA has posted the briefing materials...
Published:
Prana Biotechnology saw its shares surge on Friday, on the heels of the FDA granting an orphan drug designation to the company’s PBT2.
Published:
Merck & Co. has received approval from the FDA to bring its new drug Keytruda to market.
Published:
ThinkstockBristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) had approved the drug ELIQUIS, as a treatment for Deep...
Published:
ThinkstockTekmira Pharmaceuticals Corp. (NASDAQ: TKMR) has made a name for itself pioneering new experimental treatments in the wake of the most recent Ebola scare. Ebola is considered one of the...
Published:
ThinkstockThe world is dealing with Ebola outbreaks and scares again. We are also in the midst of debates as to whether two Americans who contracted Ebola in Africa should have been brought back for...
Published:
ThinkstockA brand new research report from RBC highlights more than 50 biotech event catalysts that are on the horizon. These are trial data, FDA decisions and company presentations coming soon. The...
Published:
ThinkstockInvestors and speculators often flock to the world biotech for emerging drugs of the future. It is no secret at all that the biotech sector is full of all sorts of risks, making and taking...
Published:
A new report from the analysts at Cowen shows that, on average, biotech stocks gained 84% in the 12 months prior to an FDA approval and lost 24% in the 12 months after the approval.
Published:
ThinkstockMannKind Corp. (NASDAQ: MNKD) has seen its shares surge on news that it has finally won U.S. Food & Drug Administration backing. This FDA approval for Type 1 and 2 diabetes is being...
Published: